Differential effects of topiramate in patients with traumatic brain injury and obesity—a case series
- 132 Downloads
Topiramate is an antiepileptic drug known to have effects on weight. In order to use this as a tool to treat eating disorders, it is useful to examine whether these effects can be predicted in certain patients.
To report the effects of topiramate, initiated for the treatment of epilepsy, on top of ongoing treatment, on eating patterns and weight of 17 patients with traumatic brain injury (TBI) with post-traumatic epilepsy and weight gain of various etiologies.
Patients were followed up according to their usual treatment plan. Topiramate was added on top of current and stable treatment. Dose was titrated based on the patients’ neurological status. Patients were asked to report side effects. No other changes were made.
Of the 17 patients included, one patient dropped out. Six patients with binge eating disorder (BED) demonstrated the most pronounced effects, with marked attenuation of binges and normalizing body mass index. Less noticeable were the effects in patients with mood disorders. Topiramate was ineffective in patients whose overweight was a side effect of their medication. Side effects were rated as mild and included somnolence, paresthesias, mild cognitive disturbances and some gastrointestinal disturbances.
In this report of the actual effects of topiramate in a clinical setting on weight and eating habits of 17 patients with TBI and obesity of various etiologies, topiramate seemed to be a safe intervention. Topiramate appeared to be differentially effective, with particular effects on primary pathological eating patterns.
KeywordsBinge eating disorder Obesity PTSD Post Traumatic Stress Disorder Topiramate Traumatic brain injury TBI Weight gain Epilepsy Side effects
- Appolinario JC, Fontenelle LF, Papelbaum M, Bueno JR, Coutinho W (2002) Topiramate use in obese patients with binge eating disorder: an open study. Can J Psychiatry 47:271–273Google Scholar
- Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH (2003) A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 11:722–733Google Scholar
- Chengappa KNR, Gershon S, Levine J (2001a) The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disord 3:215–232Google Scholar
- Colom F, Vieta E, Benabarre A, Reinares M, Corbella B, Gasto C (2001) Topiramate abuse in a bipolar patient with an eating disorder. J Clin Psychiatry 62:475–476Google Scholar
- Dursun SM, Devarajan S (2000) Clozapine weight gain, plus topiramate weight loss. Can J Psychiatry 45:198Google Scholar
- Dursun, SM, Devarajan S (2001) Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanism of action? Can J Psychiatry 46:50–51Google Scholar
- Gordon A, Price LH (1999) Mood stabilization and weight loss with topiramate. Am J Psychiatry 156:968–969Google Scholar
- National Heart, Lung and Blood Institute (NHLBI) Obesity Task Force (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6:51–209Google Scholar
- Shapira NA, Goldsmith TD, McElroy SL (2000) Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 61:368–372Google Scholar
- Van Ameringen M, Mancini C, Pipe B, Campbell M, Oakman J (2002) Topiramate treatment for SSRI-induced weight gain in anxiety disorders. J Clin Psychiatry 63:981–984Google Scholar